Skip to main content
Premium Trial:

Request an Annual Quote

UK to Change Gene-Editing Regulations

With its departure from the European Union, the UK is set to loosen its regulations surrounding gene-edited crops by the end of the year, the Financial Times reports.

It notes that the EU treats gene editing like other genetic modifications and has strict regulations governing them. Those rules require, for example, a number of field trials and food safety tests, BBC News adds.

But George Eustice, the environment secretary, is to announce a number of upcoming changes to UK policy in the wake of Brexit, FT reports. For instance, crop researchers will no longer have to apply for a license to conduct field trials and will instead only have to notify the Department for Environment, Food, and Rural Affairs of any trials, according to the BBC. Additionally, it notes that new legislation is then to be introduced to change the regulation of gene-edited crops so that it is more similar to how new crop varieties are overseen. FT adds that ministers also hope to relax regulations surrounding the gene-editing of livestock.

"Adopting a more proportionate and enabling approach to regulation will open up increased opportunities for international research collaboration, inward investment, and technology-based exports, bringing a major boost for UK science," Helen Sang from the Roslin Institute in Edinburgh tells the BBC.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.